Demand for mucinoses management will increase through 2036, with topical corticosteroids at 38.2% of the drug class segment in 2026. The market is projected to grow from USD 19.2 billion in 2026 to USD 109.2 billion by 2036, creating an incremental opportunity of USD 90.00 billion between 2026 and 2036.